Study shows soy protein alleviates symptoms of fatty liver disease

Apr 23, 2012

University of Illinois researchers report this week that new research shows how soy protein could significantly reduce fat accumulation and triglycerides in the livers of obese patients by partially restoring the function of a key signaling pathway in the organ.

Hong Chen, an assistant professor of food science and at the University of Illinois, presented her team's findings Sunday, April 22, at the annual meeting of the American Society for Biochemistry and Molecular Biology, held in conjunction with the 2012 meeting in San Diego.

"Almost a third of American adults have fatty liver disease, many of them without symptoms," Chen explained. "Obesity is a key risk factor for this condition, which can lead to ."

Fat is metabolized in the liver, and in those who are obese the transport of fat to adipose tissue can slow down to the point at which the liver becomes a dumping ground for excess fat, she said.

"When fat accumulates in an organ that's not supposed to store fat — like the liver, that organ's vital function can be dangerously compromised," she noted.

Eating soy protein, from such sources as tofu and yogurt, appears to alleviate some of the stress on fatty livers, Chen said. For her study, Chen compared fat accumulation in the livers of lean and obese rats, which were assigned to either a diet containing casein, a milk-based protein, or a diet containing soy protein, for 17 weeks after weaning.

While diet had no effect on the liver profiles of lean animals, the obese rats that were fed soy showed a 20 percent reduction in triglycerides and overall fat accumulation in the liver, leading Chen to believe that soy protein could be used to alleviate the symptoms of .

Furthermore, the scientists discovered that isolate partially restored the Wnt/β-catenin signaling pathway, a crucial player in fat metabolism. "In many obese persons, there's a sort of traffic problem, and when more fat can make its way out of the liver, there is less pressure on that organ," Chen said.

Explore further: Large-scale identification and analysis of suppressive drug interactions

Provided by American Society for Biochemistry and Molecular Biology

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Fat-free diet reduces liver fat in fat-free mice

Feb 03, 2009

Researchers at UT Southwestern Medical Center have uncovered crucial clues about a paradoxical disease in which patients with no body fat develop many of the health complications usually found in obese people.

Secreted protein sends signal that fat is on the way

Dec 02, 2008

After you eat a burger and fries or other fat-filled meal, a protein produced by the liver may send a signal that fat is on the way, suggests a report in the December issue of the journal Cell Metabolism, a Cell Press public ...

Getting to the root of fatty liver disease

Apr 05, 2011

Researchers have identified a molecular switch that appears to be a common feature in the development of fatty liver disease. The discovery made in mice is consistent with data from human patients, suggesting ...

Recommended for you

New method to analyse how cancer cells die

10 hours ago

(Phys.org) —A team from The University of Manchester – part of the Manchester Cancer Research Centre - have found a new method to more efficiently manufacture a chemical used to monitor cancer cells.

The anti-inflammatory factory

Apr 22, 2014

Russian scientists, in collaboration with their colleagues from Pittsburgh University, have discovered how lipid mediators are produced. The relevant paper was published in Nature Chemistry. Lipid mediators are molecules that p ...

User comments : 0

More news stories

Computer program could help solve arson cases

Sifting through the chemical clues left behind by arson is delicate, time-consuming work, but University of Alberta researchers teaming with RCMP scientists in Canada, have found a way to speed the process.

One in 13 US schoolkids takes psych meds

(HealthDay)—More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.

FDA reconsiders behavior-modifying 'shock devices'

(HealthDay)—They're likened to a dog's "shock collar" by some and called a "life-saving treatment" by others. But the days of electro-shock devices as a tool for managing hard-to-control behavior in people ...